glp-1 tirzepatide drops Sublingual GLP-1/GIP (Tirz) Oral Weekly Weight Loss on Tirzepatide:

Consider tirzepatide (Zepbound/Mounjaro) if: You want a proven, FDA-approved medication available today You prefer a drug with years of real-world safety data You have insurance coverage for weight management medications You have type 2 diabetes (Mounjaro is indicated for T2D) You are sensitive to GI side effects (lower nausea rate: 31% vs 43%) You want the option of pre-filled pens for easier injection Consider waiting for retatrutide if: You have plateaued on tirzepatide or semaglutide and want the next-generation option You have MASLD or fatty liver disease (glucagon component reduces liver fat by 82%) Maximum possible weight loss is your primary goal You are eligible for and enrolled in a clinical trial You are comfortable waiting until 2027-2028 for availability On switching from tirzepatide to retatrutide: Once retatrutide is approved, switching will likely be straightforward since both are Lilly products

FDA (2024)

Click here to open up a printable (pdf) copy

"Treatment not working" is not listed as a refund basis

Keep reading to learn exactly how to use glutathione for weight loss, including an amazing success story from Rebecca, who shed 70 pounds of stubborn body fat with this mighty molecule